AIR FRANCE-KLM (AF.PA)

FR001400J770 - Common Stock

8  -0.3 (-3.66%)

Fundamental Rating

2

AF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Passenger Airlines industry. AF may be in some trouble as it scores bad on both profitability and health. AF is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year AF was profitable.
AF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AF reported negative net income in multiple years.
AF had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.59%, AF is doing worse than 76.92% of the companies in the same industry.
AF's Return On Invested Capital of 4.96% is on the low side compared to the rest of the industry. AF is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
ROA 0.59%
ROE N/A
ROIC 4.96%
ROA(3y)-2.38%
ROA(5y)-5.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AF has a worse Profit Margin (0.68%) than 76.92% of its industry peers.
AF's Profit Margin has improved in the last couple of years.
AF has a worse Operating Margin (3.45%) than 84.62% of its industry peers.
AF's Operating Margin has been stable in the last couple of years.
AF has a Gross Margin (46.03%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AF has declined.
Industry RankSector Rank
OM 3.45%
PM (TTM) 0.68%
GM 46.03%
OM growth 3YN/A
OM growth 5Y-0.65%
PM growth 3YN/A
PM growth 5Y11.29%
GM growth 3Y8.53%
GM growth 5Y-1.71%

0

2. Health

2.1 Basic Checks

AF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AF has been increased compared to 1 year ago.
Compared to 5 years ago, AF has more shares outstanding
Compared to 1 year ago, AF has an improved debt to assets ratio.

2.2 Solvency

AF has an Altman-Z score of 0.36. This is a bad value and indicates that AF is not financially healthy and even has some risk of bankruptcy.
AF has a worse Altman-Z score (0.36) than 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.88
WACC5.61%

2.3 Liquidity

A Current Ratio of 0.67 indicates that AF may have some problems paying its short term obligations.
AF has a Current ratio of 0.67. This is in the lower half of the industry: AF underperforms 76.92% of its industry peers.
AF has a Quick Ratio of 0.67. This is a bad value and indicates that AF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, AF is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.62

4

3. Growth

3.1 Past

AF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.89%.
The Earnings Per Share has been growing by 54.75% on average over the past years. This is a very strong growth
Looking at the last year, AF shows a small growth in Revenue. The Revenue has grown by 4.20% in the last year.
Measured over the past years, AF shows a small growth in Revenue. The Revenue has been growing by 2.74% on average per year.
EPS 1Y (TTM)-83.89%
EPS 3YN/A
EPS 5Y54.75%
EPS Q2Q%-26.08%
Revenue 1Y (TTM)4.2%
Revenue growth 3Y39.37%
Revenue growth 5Y2.74%
Sales Q2Q%3.7%

3.2 Future

Based on estimates for the next years, AF will show a small growth in Earnings Per Share. The EPS will grow by 5.55% on average per year.
AF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.44% yearly.
EPS Next Y-37.94%
EPS Next 2Y0.05%
EPS Next 3Y4.41%
EPS Next 5Y5.55%
Revenue Next Year3.65%
Revenue Next 2Y3.83%
Revenue Next 3Y3.94%
Revenue Next 5Y3.44%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

AF is valuated cheaply with a Price/Earnings ratio of 7.62.
76.92% of the companies in the same industry are more expensive than AF, based on the Price/Earnings ratio.
AF is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 1.94 indicates a rather cheap valuation of AF.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AF indicates a rather cheap valuation: AF is cheaper than 92.31% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. AF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.62
Fwd PE 1.94

4.2 Price Multiples

AF's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AF is cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.22

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y0.05%
EPS Next 3Y4.41%

0

5. Dividend

5.1 Amount

No dividends for AF!.
Industry RankSector Rank
Dividend Yield N/A

AIR FRANCE-KLM

EPA:AF (12/20/2024, 7:00:00 PM)

8

-0.3 (-3.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners8.78%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap2.10B
Analysts70.77
Price Target10.9 (36.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-5.03%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.51%
Min EPS beat(2)-91.85%
Max EPS beat(2)-71.16%
EPS beat(4)2
Avg EPS beat(4)-28.54%
Min EPS beat(4)-91.85%
Max EPS beat(4)44.76%
EPS beat(8)5
Avg EPS beat(8)144.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.87%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)-2.31%
Revenue beat(4)0
Avg Revenue beat(4)-3.41%
Min Revenue beat(4)-4.53%
Max Revenue beat(4)-2.31%
Revenue beat(8)2
Avg Revenue beat(8)-1.73%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)6
Avg Revenue beat(16)-0.52%
PT rev (1m)-4.79%
PT rev (3m)-4.04%
EPS NQ rev (1m)24.34%
EPS NQ rev (3m)30.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.55%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)1.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.21%
Valuation
Industry RankSector Rank
PE 7.62
Fwd PE 1.94
P/S 0.07
P/FCF N/A
P/OCF 1.09
P/B N/A
P/tB N/A
EV/EBITDA 2.22
EPS(TTM)1.05
EY13.13%
EPS(NY)4.12
Fwd EY51.52%
FCF(TTM)-8.73
FCFYN/A
OCF(TTM)7.34
OCFY91.76%
SpS116.71
BVpS-8.75
TBVpS-13.91
PEG (NY)N/A
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA 0.59%
ROE N/A
ROCE 5.79%
ROIC 4.96%
ROICexc 7.66%
ROICexgc 8.65%
OM 3.45%
PM (TTM) 0.68%
GM 46.03%
FCFM N/A
ROA(3y)-2.38%
ROA(5y)-5.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y5.37%
ROICexc growth 3YN/A
ROICexc growth 5Y5.1%
OM growth 3YN/A
OM growth 5Y-0.65%
PM growth 3YN/A
PM growth 5Y11.29%
GM growth 3Y8.53%
GM growth 5Y-1.71%
F-Score5
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3
Cap/Depr 160.59%
Cap/Sales 13.77%
Interest Coverage 1.72
Cash Conversion 52.3%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.62
Altman-Z 0.36
F-Score5
WACC5.61%
ROIC/WACC0.88
Cap/Depr(3y)119.28%
Cap/Depr(5y)108.83%
Cap/Sales(3y)12.82%
Cap/Sales(5y)13.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.89%
EPS 3YN/A
EPS 5Y54.75%
EPS Q2Q%-26.08%
EPS Next Y-37.94%
EPS Next 2Y0.05%
EPS Next 3Y4.41%
EPS Next 5Y5.55%
Revenue 1Y (TTM)4.2%
Revenue growth 3Y39.37%
Revenue growth 5Y2.74%
Sales Q2Q%3.7%
Revenue Next Year3.65%
Revenue Next 2Y3.83%
Revenue Next 3Y3.94%
Revenue Next 5Y3.44%
EBIT growth 1Y-25.89%
EBIT growth 3YN/A
EBIT growth 5Y2.07%
EBIT Next Year134.9%
EBIT Next 3Y41.96%
EBIT Next 5Y25.39%
FCF growth 1Y-184.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.51%
OCF growth 3YN/A
OCF growth 5Y-3.83%